Natural killer cell activity and prostate cancer risk in veteran men undergoing prostate biopsy.

Natural killer cell activity and prostate cancer risk in veteran men undergoing prostate biopsy.
复制标题

DOI:
10.1016/j.canep.2019.101578
复制
发表时间:
2019-10
影响因子:
2.6
通讯作者:
Freedland SJ
Freedland SJ
中科院分区:
医学3区
文献类型:
--
作者:
Vidal AC;Howard LE;Wiggins E;De Hoedt AM;Shiao SL;Knott S;Taioli E;Fowke JH;Freedland SJ

文献摘要

参考文献

被引文献

相似文献

A previous pilot study found that men with a positive prostate biopsy had low numbers of circulating natural killer (NK) cells, compared to biopsy negative men. To confirm these data, we analyzed differences in NK cells from 94 men undergoing prostate biopsy to determine whether NK cells could predict for a positive biopsy. NK cells activity (NKA) was measured by an in vitro diagnostic system, with a pre-defined cut-off value for NKA at 200 pg/mL. Logistic regression and receiver operator characteristics (Area Under the Curve (AUC)) analyses were used to test the diagnostic value of NKA. The NKA test performance showed specificity of 88%, positive predictive value of 84%, sensitivity of 34%, and a negative predictive value of 41%. Among the 94 men analyzed, NKA was not significantly linked with age, race, digital rectal examination (DRE), prostate volume, PSA or biopsy grade group (all P ≥ 0.14). In multivariable logistic regression analysis, the odds ratio (OR) of low NKA (< 200 pg/mL) for the detection of PC was 4.89, 95%CI 1.34–17.8, with a ROC area under the curve of 0.79 in all participants and increasing to 0.83 and 0.85 for the detection of PC and high-grade PC, respectively, among men with a normal DRE. Men with a low NKA value had five-times higher odds of PC at biopsy. The implementation of this NKA assay in the clinic together with PSA may help to advise patients with the highest risk of PC whether, or not, to undergo a prostate biopsy.
DOI: 10.1371/journal.pone.0078049
发表时间: 2013
期刊: PloS one
影响因子: 3.7
作者:
Koo KC;Shim DH;Yang CM;Lee SB;Kim SM;Shin TY;Kim KH;Yoon HG;Rha KH;Lee JM;Hong SJ
通讯作者: Hong SJ
DOI: 10.2147/ott.s169094
发表时间: 2018
影响因子: 4
作者:
Song W;Yu JW;Jeong BC;Seo SI;Jeon SS;Lee HM;Choi HY;Kang ES;Jeon HG
通讯作者: Jeon HG
DOI: 10.1016/s0065-2776(08)60664-1
发表时间: 1989
影响因子: --
作者:
Trinchieri G
通讯作者: Trinchieri G
DOI: 10.18632/oncotarget.3965
发表时间: 2015-06-10
期刊: Oncotarget
影响因子: --
作者:
Pasero C;Gravis G;Granjeaud S;Guerin M;Thomassin-Piana J;Rocchi P;Salem N;Walz J;Moretta A;Olive D
通讯作者: Olive D
DOI: 10.1016/j.jim.2018.04.002
发表时间: 2018-07-01
影响因子: 2.2
作者:
Nederby, Line;Jakobsen, Anders;Hansen, Torben Frostrup
通讯作者: Hansen, Torben Frostrup